89bio Inc. (ETNB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    89bio Inc.

    NASDAQ: ETNB · Real-Time Price · USD
    14.85
    0.01 (0.07%)
    At close: Oct 03, 2025, 3:59 PM
    14.90
    0.34%
    After-hours: Oct 03, 2025, 07:20 PM EDT

    89bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 38K 273K 240K 79K
    Gross Profit
    		 -38K -273K -240K -79K
    Operating Income
    		 -384.66M -151.2M 102.25M -89.74M
    Interest Income
    		 n/a n/a 2.16M 148K
    Pretax Income
    		 -366.39M -138.32M -102.01M -90.27M
    Net Income
    		 -367.08M -142.19M -102.03M -90.12M
    Selling & General & Admin
    		 39.62M 28.97M 21.45M 19.41M
    Research & Development
    		 345.04M 122.23M 80.8M 70.33M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 384.66M 151.2M 102.25M 89.74M
    Interest Expense
    		 3.79M 3.59M 1.92M 674K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 384.66M 151.2M 102.25M 89.74M
    Income Tax Expense
    		 692K 3.87M 19K -147K
    Shares Outstanding (Basic)
    		 104.71M 71.17M 34.81M 20.1M
    Shares Outstanding (Diluted)
    		 104.71M 71.17M 34.81M 20.1M
    EPS (Basic)
    		 -3.51 -2 -2.93 -4.48
    EPS (Diluted)
    		 -3.51 -2 -2.93 -4.48
    EBITDA
    		 -384.66M -134.46M -99.84M -90.19M
    EBIT
    		 -371.68M -134.74M -100.08M -90.27M
    Depreciation & Amortization
    		 -12.98M 273K 240K 79K

    Add to Watchlist